Article thumbnail

Toward Best Practice in Using Molecular Diagnosis to Guide Medical Management, Are We There Yet?

By Anne Chun-hui Tsai and Xuezhong Liu

Abstract

Molecular genetics testing has made several huge breakthroughs in the past two decades and many molecular technologies have been applied to our daily medical progress. However, the clinical utility has not reach a consensus by the medical and genetic peers as well as third party payers. The predictive value and clinical applications are variable from one condition to the other. Numerous questions remain including technology deficits, data interpretation and unpredicted phenotypes in complex disorders. In this commentary, the authors reviewed the historical perspective of genetic testing and summarized the current technical deficit, clinical dilemma and suggested a few critical threshold to overcome before the implementation of useful genetic information in standard health care can become a reality

Topics: Key Words, clinical genetics, effective molecular genetic testing, predictive power, panel analysis, exome, next generation re-sequencing, clinical application
Year: 2016
OAI identifier: oai:CiteSeerX.psu:10.1.1.1024.1998
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.najms.com/index.php... (external link)
  • http://www.najms.com/index.php... (external link)
  • http://citeseerx.ist.psu.edu/v... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.